Part Details | CLORAZEPATE DIPOTASSIUM TABLETS
6505-01-251-1850
Alternate Parts: NDC00074439053, NDC00074-4390-53, TRANXENE, NDC53265004950, NDC53265-0049-50, NDC00228306850, NDC00228-3068-50, NDC00591036405, NDC00591-0364-05, NDC00378004005, NDC00378-0040-05, NDC51672404302, NDC51672-4043-02, 6505-01-251-1850, 01-251-1850, 6505012511850, 012511850
| Supply Group (FSG) | NSN Assigned | NIIN | Item Name Code (INC) |
|---|---|---|---|
| 65 | MAR 14, 1987 | 01-251-1850 | 66760 ( CLORAZEPATE DIPOTASSIUM TABLETS ) |
REFERENCE DRAWINGS & PICTURES
Cross Reference | NSN 6505-01-251-1850
| Part Number | Cage Code | Manufacturer |
|---|---|---|
| NDC00074-4390-53 | 70048 | ABBOTT LABORATORIESPHARMACEUTICAL PRODUCTS DIV |
| TRANXENE | 70048 | ABBOTT LABORATORIESPHARMACEUTICAL PRODUCTS DIV |
| NDC53265-0049-50 | 0E5C1 | ABLE LABORATORIES |
| NDC00228-3068-50 | 56287 | ACTAVIS ELIZABETH LLCDBA ACTAVIS US |
| NDC00591-0364-05 | 62051 | DANBURY PHARMACAL INC |
| NDC00378-0040-05 | 60895 | MYLAN PHARMACEUTICALS INC |
| NDC51672-4043-02 | 0MLD2 | TARO PHARMACEUTICALS USA INC |
Technical Data | NSN 6505-01-251-1850
| Characteristic | Specifications |
|---|---|
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | AB7.500 MILLIGRAMS CLORAZEPATE DIPOTASSIUM |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PRIMARY CONTAINER CONTENT QUANTITY | 500.000 TABLETS |
| SPECIAL FEATURES | SCHEDULE IV CONTROLLED SUBSTANCE CLASSIFICATION |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | CLORAZEPATE DIPOTASSIUM TABLETS USP 500S BT |